As the Indian primary market sees heightened activity, three IPOs — Ventive Hospitality, Senores Pharmaceuticals, and Carraro India — have closed today, 24 December 2024. These IPOs aim to cumulatively raise over INR 3,432.11 crore. Here’s a comprehensive look at their Day 3 subscription status and grey market premiums (GMPs):
Subscription of all IPOs at a glance (X no. of times)
Ventive Hospitality IPO: Strong Demand and Promising GMP
Pune-based Ventive Hospitality is offering shares in the price range of INR 610 – 643 per share. Investors can apply for a minimum lot size of 23 shares, and the minimum application amount is INR 14,789. The IPO seeks to raise INR 1,600 crore through a fresh issue of 2,48,83,358 equity shares.
As of 5:00 PM on 24 December 2024, Ventive Hospitality IPO was oversubscribed 9.80 times. Retail investors subscribed 5.87 times, non-institutional investors (NIIs) subscribed 13.85 times, employees subscribed 9.49 times, and qualified institutional buyers (QIBs) subscribed 9.08 times.
As of today, Ventive Hospitality IPO GMP stood at INR 45, indicating an expected listing gain of 7-9%. The robust demand suggests high investor confidence and the potential for favorable listing gains, making Ventive Hospitality IPO one of the notable IPOs closing today.
Carraro India IPO: Full Subscription, Aided by QIBs
Carraro India is offering shares in the price band of INR 668 – 704 per share, targeting INR 1,250 crore entirely through an offer-for-sale (OFS) of 1,77,55,680 equity shares. Investors can apply for a minimum lot size of 21 shares, and the minimum application amount is INR 14,784.
By 5:00 PM, 24 December 2024, the IPO received bids for 1,46,18,205 equity shares, translating to 1.12 times the total issue size. Retail investors subscribed 71%, NIIs subscribed 60%, and QIBs subscribed 2.21 times.
No grey market premium has been observed since the IPO announcement. Carraro India IPO’s subdued interest suggests cautious investor sentiment, contrasting with the enthusiasm seen in other IPOs closing today.
Senores Pharmaceuticals IPO: Exceptional Oversubscription and High GMP
Ahmedabad-based Senores Pharmaceuticals has priced its IPO between INR 372 – 391 per share. Investors can apply for a minimum lot size of 38 shares, and the minimum application amount is INR 14,858. The IPO seeks to raise INR 582.11 crore, comprising INR 500 crore from a fresh issue and an OFS of 21 lakh equity shares. The shares are expected to be listed on the BSE and NSE on 30 December 2024.
By 5:00 PM, 24 December 2024, the IPO was oversubscribed 93.41 times. Retail investors subscribed 89.22 times, NIIs subscribed 96.11 times, employees subscribed 19.92 times, and QIBs subscribed 94.66 times.
The GMP stood at INR 222, projecting a listing gain of approximately 57%. Senores Pharmaceuticals IPO emerged as the top performer among IPOs closing today, reflecting strong investor interest and anticipation of significant listing gains.
Final Thoughts: Evaluating IPOs Closing Today
With diverse investor responses and varied grey market premiums, the IPOs closing today offer different levels of promise and risk. Ventive Hospitality shows balanced demand across categories, while Senores Pharmaceuticals has witnessed overwhelming enthusiasm, pointing to substantial listing gains. Meanwhile, Carraro India’s lukewarm reception suggests a more cautious approach from investors.
Investors are advised to carefully assess fundamentals, valuations, and post-listing potential before making final investment decisions. Monitoring GMP trends and subscription data can provide further insights into market sentiment for IPOs closing today. For more information related to IPO GMP, SEBI IPO Approval, and Live Subscription, stay tuned to IPO Central.
IPOs Closing Today FAQs
Which IPOs are closing today?
The IPOs closing today are Ventive Hospitality, Senores Pharmaceuticals, and Carraro India.
What is the total amount these IPOs aim to raise?
Collectively, these IPOs aim to raise over INR 3,432.11 crore.
When will the allotment and listing dates occur?
Allotment for these IPOs is expected to be finalized on December 26, 2024, with shares tentatively listing on the exchanges on December 30, 2024.
What factors should investors consider before participating in these IPOs?
Investors should evaluate fundamentals, valuations, and potential post-listing performance, along with monitoring GMP trends and subscription data for insights into market sentiment.
